InnovAge Holding Corp. (INNV)

InnovAge Holding Corp. (INNV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

InnovAge Holding Corp. (NASDAQ: INNV - Get Free Report) traded up 8.5% on Monday after JPMorgan Chase and Co. raised their price target on the stock from $5.00 to $7.00. JPMorgan Chase and Co. currently has an underweight rating on the stock. InnovAge traded as high as $8.80 and last traded at $8.8540. 49,382 shares traded

InnovAge Holding Corp. delivers strong operational execution, driving significant revenue and margin expansion through its PACE model for elderly care. INNV's revenue rose 14.7% year-over-year, fueled by participant growth and capitation rate adjustments across established centers. Disciplined cost management and SG&A reductions have expanded center-level contribution margin to 22% and adjusted EBITDA margin to 9.2%.

Aclarion (NASDAQ: ACON - Get Free Report) and InnovAge (NASDAQ: INNV - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership. Volatility and Risk Aclarion has a beta of 1.44,

InnovAge (INNV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

DENVER, Feb. 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leading Program of All-Inclusive Care for the Elderly (PACE) provider, in partnership with LeadingAge Colorado, met with state lawmakers today at the Colorado State Capitol to underscore the importance of protecting and strengthening care for Colorado's aging population, including through PACE. Seniors enrolled in InnovAge Colorado PACE met with several lawmakers to share firsthand how the program delivers comprehensive, person-centered care that allows older adults to remain living safely and independently in their homes and communities.

InnovAge Holding Corp. (INNV) Q2 2026 Earnings Call Transcript

InnovAge Holding Corp. (INNV) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to a loss of $0.1 per share a year ago.

DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2025. “InnovAge delivered strong operating and financial results this quarter, reflecting continued progress in building a scalable, high-quality PACE platform,” said Patrick Blair, CEO.

DENVER, Jan. 29, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the appointment of Pavithra Mahesh and Sean Traynor to its Board of Directors (the “Board”), effective immediately. Ms. Mahesh will serve as a Class III director and as a member of the Quality and Compliance Committee, and Mr.

First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and InnovAge (NASDAQ: INNV - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Profitability This table compares First Choice

InnovAge (NASDAQ: INNV - Get Free Report) is expected to be releasing its Q2 2026 results after the market closes on Tuesday, February 3rd. Analysts expect InnovAge to post earnings of $0.04 per share and revenue of $228.30 million for the quarter. Interested persons can find conference call details on the company's upcoming Q2 2026 earning

DENVER, Jan. 21, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal second quarter financial results on Tuesday, February 3, 2026, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m.

InnovAge Holding Corp. (INNV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

InnovAge (NASDAQ: INNV - Get Free Report) and Revvity (NYSE: RVTY - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Insider and Institutional Ownership 12.3% of InnovAge shares are owned

Agilon Health (NYSE: AGL - Get Free Report) and InnovAge (NASDAQ: INNV - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings. Risk and Volatility Agilon Health has a beta